Testing effectiveness (Phase 2)Active Not RecruitingNCT02648997
What this trial is testing
An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
Who this might be right for
Meningiomas
Dana-Farber Cancer Institute 40